Evidence map›Paper›PMID 21355056›Full record

ArticleJournal of the American Society of Nephrology : JASN2011

Screening for NPHS2 mutations may help predict FSGS recurrence after transplantation.

Therese C Jungraithmayr, Katrin Hofer, Pierre Cochat, Gil Chernin, Gerard Cortina, Sonja Fargue, Paul Grimm, Tanja Knueppel, Andreas Kowarsch, Thomas Neuhaus and 10 more

Abstract read
In one paragraph

Article in Journal of the American Society of Nephrology : JASN, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed.

  1. Proteinuria After Kidney Transplantation.Pediatric transplantation · 2025
    Review
  2. Evaluation for genetic disease in kidney transplant candidates: A practice resource.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2025
    Review
  3. Steroid-Resistant Nephrotic Syndrome due toKidney international reports · 2024
    Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. COQ8B nephropathy: Early detection and optimal treatment.Molecular genetics & genomic medicine · 2020
    Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Recurrent andFrontiers in immunology · 2019
    Review
  18. Review
  19. Genetic Basis of Health Disparity in Childhood Nephrotic Syndrome.American journal of kidney diseases : the official journal of the National Kidney Foundation · 2018
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Therese C JungraithmayrUniversitäts-Kinderklinik Innsbruck, Anichstrasse 35, Innsbruck, Austria. therese.jungraithmayr@uki.at
Katrin Hofer
Pierre Cochat
Gil Chernin
Gerard Cortina
Sonja Fargue
Paul Grimm
Tanja Knueppel
Andreas Kowarsch
Thomas Neuhaus
Philipp Pagel
Karl P Pfeiffer
Franz Schäfer
Ulf Schönermarck
Tomas Seeman
Burkhard Toenshoff
Stefanie Weber
Michelle P Winn
Johannes Zschocke
Lothar B Zimmerhackl

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Steroid-resistant focal segmental glomerulosclerosis (FSGS) often recurs after renal transplantation. In this international survey, we sought to identify genotype-phenotype correlations of recurrent FSGS. We surveyed 83 patients with childhood-onset primary FSGS who received at least one renal allograft and analyzed 53 of these patients for NPHS2 mutations. The mean age at diagnosis was 6.7 years, and the mean age at first renal transplantation was 13 years. FSGS recurred in 30 patients (36%) after a median of 13 days (range, 1.5 to 152 days). Twenty-three patients received a second kidney transplant, and FSGS recurred in 11 (48%) after a median of 16 days (range, 2.7 to 66 days). None of the 11 patients with homozygous or compound heterozygous NPHS2 mutations developed recurrent FSGS compared with 45% of patients without mutations. These data suggest that genetic testing for pathogenic mutations may be important for prognosis and treatment of FSGS both before and after transplantation.

Indexed as

Genetic TestingKidney TransplantationAdolescentAdultChildChild, PreschoolFemaleGenetic Association StudiesGlomerulosclerosis, Focal SegmentalGraft SurvivalHeterozygoteHomozygoteHumansInfantIntracellular Signaling Peptides and ProteinsMaleIntracellular Signaling Peptides and ProteinsMembrane ProteinsNPHS2 protein

Identifiers

PMID21355056
PMCPMC3060451

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.